Next Article in Journal
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan
Next Article in Special Issue
A Novel Integrated Biomarker for Evaluation of Risk and Severity of Coronary Atherosclerosis, and Its Validation
Previous Article in Journal
Detecting Blastocyst Components by Artificial Intelligence for Human Embryological Analysis to Improve Success Rate of In Vitro Fertilization
Previous Article in Special Issue
The Determinants of the 13-Year Risk of Incident Atrial Fibrillation in a Russian Population Cohort of Middle and Elderly Age
 
 
Article

Article Versions Notes

J. Pers. Med. 2022, 12(2), 129; https://doi.org/10.3390/jpm12020129
Action Date Notes Link
article xml file uploaded 19 January 2022 07:58 CET Original file -
article xml uploaded. 19 January 2022 07:58 CET Update https://www.mdpi.com/2075-4426/12/2/129/xml
article pdf uploaded. 19 January 2022 07:58 CET Version of Record https://www.mdpi.com/2075-4426/12/2/129/pdf
article html file updated 19 January 2022 08:00 CET Original file -
article html file updated 19 January 2022 08:00 CET Update -
article html file updated 31 July 2022 04:36 CEST Update https://www.mdpi.com/2075-4426/12/2/129/html
Back to TopTop